Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisited

American Journal of Kidney Diseases

Volumn 25, Issue 5, 1995, Pages 663-679

  Llach, Francisco ^a  

^a NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

calcitriol; chronic renal failure; hyperphosphatemia; Secondary hyperparathyroidism; trade off hypothesis

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR;

CALCIUM MOBILIZATION; HORMONE SYNTHESIS; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPOCALCEMIA; KIDNEY FAILURE; NONHUMAN; PARATHYROID FUNCTION; PATHOGENESIS; REVIEW; UREMIA; VITAMIN D METABOLISM;

CALCITRIOL; HUMAN; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; PHOSPHORUS;

EID: 0029005503     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/0272-6386(95)90541-3     Document Type: Review

References (168)

1. On a form of late rickets associated with albuminuria rickets of adolescents
2. Tumor of the parathyroid gland
3. Metabolic studies of renal osteodystrophy I Calcium phosphorus and nitrogen metabolism in rickets osteomalacia and hyperparathyroidism complicating chronic uremia and the osteomalacia of the adult Franconi syndrome
4. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in renal disease
5. Renal rickets associated with parathyroid hyperplasia
6. Renal osteitis fibrosa cystica: Report of case with discussion of metabolic aspects
7. Enlargement of the parathyroid glands in renal disease
8. Bone histology in incipient and advanced renal failure
9. Calcium, phosphorus and bone in renal disease and transplantation
10. On the pathogenesis of hyperparathyroidism in chronic experimental insufficiency in the dog
11. Direct regulation by calcium of cytoplasmatic messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells
12. Hypocalcemia increases and hypercalcemia decreases the steady state level of parathyroid hormone messenger ribonucleic acid in the rat
13. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat
14. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure
15. Vitamin D metabolites in early renal failure
16. On the mechanism of the prevention of secondary hyperparathyroidism in moderate renal insufficiency
17. Effect of dietary phosphorus on circulating concentrations of 1,25 dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency
18. 2D
19. Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure
20. Effect of dietary phosphorus (P) in the phosphaturic and calcemic response to parathyroid hormone (PTH) in the uremic dog
21. Hypercalcemia and hypophosphatemia in ponies following bilateral nephrectomy
22. Hypercalcemia after nephrectomy in the dog: Role of the kidney and parathyroid glands
23. Trade off hypothesis
24. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake
25. The role of phosphate in the secretion of parathyroid hormone in man
26. Long term effects of high phosphate intake on parathyroid hormone levels and bone metabolism
27. Bone and soft tissue changes with oral phosphate supplements
28. Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. I. Association of bone disease with potentially etiologic factors
29. Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. II. Factors affecting serum immunoreactive parathyroid hormone
30. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease
31. Skeletal resistance of endogenous parathyroid hormone in patients with early renal failure
32. Intestinal absorption of calcium, magnesium, and phosphorus in chronic renal insufficiency
33. How important is phosphate in the pathogenesis of renal osteodystrophy?
34. Phosphate loading as a test for primary hyperparathyroidism
35. Early dietary phosphorus restriction and calcium supplementation in the prevention of renal osteodystrophy
36. Phosphorus excretion in renal failure
37. The control of phosphate excretion in uremia
38. Control of phosphate excretion in uremic man
39. The phosphaturic action of PTH in the steady state in patients with normal and impaired renal function
40. Effect of inorganic phosphate on serum ionized calcium concentration in vitro: A reassessment of the “trade-off hypothesis”
41. Studies of the mechanism by which phosphate infusion lowers serum calcium concentration
42. The control of 25 hydroxyvitamin D metabolism by inorganic phosphorus
43. Oral intake of phosphorus can determine the serum concentration of 1,25 D by determining its production rate in humans
44. Evidence that resistance to the calcemic action of parathyroid hormone in rats with acute uremia is caused by phosphate retention
45. Calcemic response to parathyroid hormone in renal failure: Role of phosphorus and its effect on calcitriol
46. 1,25 dihydroxycholecalciferol and parathyroid hormone in advanced renal failure: Effect of simultaneous protein and phosphorus restriction
47. Calcium salts of ketoacids as a new treatment strategy for uremic hyperphosphatemia
48. Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure
49. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol
50. In advanced renal failure, dietary phosphorus restriction reverses hyperparathyroidism independent of changes in the levels of calcitriol
51. Elevation of serum phosphate affects parathyroid hormone levels in only 50% of hemodialysis patients, which is unrelated to changes in serum calcium
52. The effect of long-term calcitriol administration on parathyroid function in hemodialysis patients
53. Mild dietary phosphorus restriction directly prevents enhanced parathyroid hormone secretion and synthesis and proliferation of parathyroid cells in chronic renal failure in rats
54. The response to the infusion of parathyroid extract in hypocalcemic states
55. Skeletal resistance to parathyroid hormone in renal failure: Study in 105 human subjects
56. Action of phosphorus on calcium release in isolated perfused rat tails
57. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclasts formation and decreased activity of mature osteoclasts
58. 3
59. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites
60. Resistance to parathyroid hormone in renal failure: Role of vitamin D metabolites
61. Calcemic response to parathyroid hormone in renal failure: Role of calcitriol and the effect of parathyroidectomy
62. Role of 1,25 dihydroxyvitamin D on the skeletal resistance to parathyroid hormone
63. Extraction of parathyroid hormone and release of cyclic-AMP by isolated perfused bones obtained from dogs with acute uremia
64. Abnormal skeletal response to parathyroid hormone in dogs with chronic uremia
65. The effect of azotemia and the magnitude of hyperparathyroidism on the calcemic response to parathyroid hormone
66. Calcitonin, an important factor in the calcemic response to parathyroid hormone in the rat with renal failure
67. Factors in the development of secondary hyperparathyroidism in during graded renal failure in the rat
68. The effect of uremic metabolites on parathyroid extract induced bone resorption in vitro
69. Basic and clinical concepts related to vitamin D metabolism and action
70. Chronic renal failure and vitamin D metabolites: A status report
71. Studies of calcium and phosphorus metabolism with special reference to pathogenesis and effects of dihydrotachysterol (AT 10) and iron
72. Metabolic studies of low protein diets in uremia. II. Calcium, phosphorus and magnesium
73. Intestinal absorption of calcium and the effect of renal insufficiency
74. Unique biosynthesis by kidney of a biologically active vitamin D metabolite
75. Isolation and identification of 1,25 dihydroxycholecalciferol
76. Vitamin D metabolism: The role of kidney tissue
77. Failure of formation of 1,25 dihydroxycholecalciferol in chronic renal insufficiency
78. Metabolism of 1,2 H3-4-C14-cholecalciferol in normal, uremic and anephric subjects
79. 3
80. 2D levels in renal disease
81. 1,25 Dihydroxyvitamin D in biological fluids: A simplified and sensitive assay
82. 3 in normal man and patients with renal failure
83. 3 in uremic man
84. Phosphate control and 25 hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog
85. Vitamin D and calcium transport
86. Circulating vitamin D metabolite concentrations in childhood renal diseases
87. Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyperparathyroidism
88. Reduced plasma concentration of 1,25 dihydroxyvitamin D in children with moderate renal insufficiency
89. The role of calcitriol in the secondary hyperparathyroidism (HPTH) of chronic renal failure (CRF)
90. 3 in early renal failure
91. Effects of renal failure and dialysis on divalent ion metabolism
92. Acute response of plasma 1,25-dihydroxyvitamin D to parathyroid hormone
93. 3 in the rat
94. Production and degradation of calcitriol in renal failure rats
95. Factors influencing calcitriol metabolism in renal failure
96. Metabolic clearance rate and production rate of calcitriol in uremia
97. Calcitriol metabolism in patients with chronic renal failure
98. Mechanism of decreased calcitriol degradation in renal failure
99. Cloning and characterization of an extracellular Ca-sensing receptor from bovine parathyroid
100. Mutation in the human Ca-sensing receptor gene causes familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism
101. Calcium infusion suggests a “set-point” abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism
102. Extrarrenal production of calcitriol
103. 3-1ahydroxylase and its responsiveness to parathyroid hormone in chick
104. The acute effects of 1,25 dihydroxycholecalciferol on serum immunoreactive parathyroid hormone in the dog
105. Regulation by vitamin D metabolites of messenger ribonucleic acid for pre-proparathyroid hormone in isolated bovine parathyroid cells
106. 3 of transcription of the pre-proparathyroid hormone gene
107. Regulation by vitamin D metabolites of parathyroid hormone gene in vivo by the rat
108. Regulation of parathyroid cell gene expression in experimental uremia
109. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25 dihydroxycholecalciferol in uremic patients
110. Parathyroid hormone suppression by intravenous 1,25 dihydroxyvitamin D
111. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis patients
112. 3
113. Vitamin D hormone receptors: Structure, regulation and molecular function
114. 3 receptors in experimental uremia
115. 2D receptors are decreased in parathyroid glands from chronically uremic dogs
116. 3 in the parathyryoid glands of patients with renal failure
117. 3 receptor content in cultured LLC-PK1 kidney cells limits hormonal responsiveness
118. 3 in the parathyroid in vivo
119. Regulation in vivo of vitamin D receptor in uremia
120. 3 on cytosolic calcium in dispersed parathyroid cells
121. Regulation of parathyroid hormone synthesis in chronic renal failure in rats
122. Mechanism of decreased intestinal calcitriol receptor concentration in renal failure
123. Calcitriol receptors after correction of uremia
124. 3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids
125. Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure
126. Secondary hyperparathyroidism in chronic haemodialysis patients: A clinico-pathological study
127. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients
128. Case records of the Massachusetts General Hospital
129. Autonomous secondary hyperparathyroidism
130. Tertiary hyperparathyroidism
131. Parathyroid morphology in suppressible and non-suppressible renal hyperparathyroidism
132. Decrease of tumor-like calcification in uremia despite aggravation of secondary hyperparathyroidism: A case report
133. Factors related to the recurrent hyperfunction of autografts after total parathyroidectomy in patients with severe secondary hyperparathyroidism
134. Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue
135. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients
136. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells
137. Progression of uremic osteodystrophy involves allelic loss on chromosome 11
138. Parathyroid hormone: Alterations in chronic renal failure
139. Immunochemical heterogeneity of parathyroid hormone in plasma
140. Parathyroid hormone: Coming of age in clinical medicine
141. Biosynthesis of parathyroid hormone
142. Episodic fluctuation in serum intact parathyroid hormone concentration in men
143. Pulsatile secretion of parathyroid hormone in patients with chronic renal failure
144. Expression of human parathyroid hormone 1–84 in E. coli as a factor x-cleavable fusion protein
145. Bovine parathyroid hormone: Minimum chain length of synthetic peptide required for biological activity
146. The carboxy-terminus of parathyroid hormone is essential for hormone processing and secretion
147. Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood
148. Sites of clearance of endogenous parathyroid hormone in the vitamin D deficient dog
149. Selective uptake of intact parathyroid hormone by the liver
150. Metabolism of immunoreactive parathyroid hormone in the dog
151. Degradation of parathyroid hormone and fragment production by the isolated perfused dog kidney
152. The renal handling of parathyroid hormone
153. Characterization of parathyroid hormone fragments produced by cathepsin D
154. Impaired parathyroid hormone metabolism in patients with chronic renal failure
155. Clearance of exogenous parathyroid hormone in normal and uraemic man
156. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients
157. Sigmoidal relationship between parathyroid hormone secretion rate and plasma calcium concentration in calves
158. Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure
159. Parathyroid hormone and bone histology: Response to hypocalcemia in osteitis fibrosa
160. Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism
161. Parathyroid gland function in chronic renal failure
162. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia
163. Expression of insulin-like growth factor-1 in uremic rats: Growth hormone resistance and nutritional intake
164. Insulin resistance in uremia
165. Insulin resistance is present in moderate uraemia and correlated to the maximal aerobic work capacity